Apogee Therapeutics, Inc. (APGE)
135.06
+0.08
(+0.06%)
USD |
NASDAQ |
Aug 31, 16:00
135.06
0.00 (0.00%)
After-Hours: 20:00
Apogee Therapeutics Cash and Short Term Investments (Quarterly) : 971.93M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 971.93M |
| March 31, 2026 | 1.060B |
| December 31, 2025 | 730.19M |
| September 30, 2025 | 527.29M |
| June 30, 2025 | 505.42M |
| March 31, 2025 | 513.33M |
| December 31, 2024 | 520.65M |
| September 30, 2024 | 526.05M |
| Date | Value |
|---|---|
| June 30, 2024 | 676.23M |
| March 31, 2024 | 816.20M |
| December 31, 2023 | 395.46M |
| September 30, 2023 | 422.85M |
| June 30, 2023 | 125.07M |
| March 31, 2023 | 141.33M |
| December 31, 2022 | 151.89M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 792.30M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Intellia Therapeutics, Inc. | 437.76M |
| Revolution Medicines, Inc. | 3.938B |
| Erasca, Inc. | 268.74M |